Home » Topics » Science » New compound

New compound
RSS

Potent, non-redox 5-LO inhibitor identified by Merck Frosst

Oct. 25, 1996

Bristol-Myers Squibb describes potent and selective beta3-adrenoceptor agonist

Oct. 25, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

New FLAP inhibitor presented by Abbott

Oct. 18, 1996

CGP-57698: Follow-up compound to iralukast reported by Ciba-Geigy

Oct. 18, 1996

Menarini studies LTD4 antagonists for asthma Rx

Oct. 18, 1996

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...